Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hypertension in pregnancy

¹Department of Medicine, Ostra Hospital, University of Göteborg, Sweden.

Clinical and Experimental Hypertension (New York, N.Y. : 1993)

|November 1, 1993

Summary

This summary is machine-generated.

Hypertension in pregnancy, a significant cause of maternal complications, affects less than 5% of pregnancies. Delivery is the primary treatment for late-stage hypertension, while long-term follow-up is crucial for detecting future chronic hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Suicidal ideation in patients with skin conditions: A multicentre European study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Same author

A cross-sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical and psychological variables.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient-Oriented Outcomes and Urticaria and Angioedema.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Prevalence of prurigo nodularis in Sweden.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Same author

Quality of life measurement in rosacea. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Area of Science:

Obstetrics and Gynecology
Cardiovascular Medicine

Background:

Hypertension in pregnancy remains a leading cause of maternal morbidity and mortality.
Pathogenesis of hypertensive disorders in pregnancy is not fully understood, leading to varied definitions and incidences.
Clinically significant blood pressure elevation complicates less than 5% of pregnancies globally.

Purpose of the Study:

To review current understanding and management of hypertension in pregnancy.
To highlight the importance of long-term follow-up for affected women.

Main Methods:

Literature review and synthesis of existing data on hypertensive disorders of pregnancy.
Analysis of treatment strategies and long-term outcomes.

Main Results:

Related Experiment Videos

Delivery is the established treatment for hypertension in late pregnancy.
Use of antihypertensive drugs for mild to moderate cases has decreased.
Low-dose aspirin shows potential for prevention in high-risk pregnancies, but requires further evidence.
A significant proportion of women with pregnancy-induced hypertension develop chronic hypertension later in life.

Conclusions:

Effective management of hypertension in pregnancy requires clear definitions and understanding of its causes.
Delivery remains the definitive treatment for severe cases.
Long-term monitoring is essential for identifying women at risk of developing chronic hypertension post-pregnancy.